Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Beta Drugs Ltd

NSE :BETA   BSE :535022  Sector : Pharmaceuticals
Buy, Sell or Hold BETA? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

12 Nov
2070.80
(-4.94%)
11 Nov
2178.40
(-0.71%)
08 Nov
2194.00
(1.57%)
07 Nov
2160.15
(8.85%)
06 Nov
1984.50
(2.08%)
05 Nov
1944.15
(-1.87%)
04 Nov
1981.25
(0.50%)
01 Nov
1971.30
(2.86%)
31 Oct
1916.55
(0.40%)
30 Oct
1908.85
(-1.74%)
29 Oct
1942.60
(7.81%)
28 Oct
1801.90
(7.11%)
25 Oct
1682.35
(-3.47%)
24 Oct
1742.85
(1.72%)
23 Oct
1713.30
(0.33%)
22 Oct
1707.70
(-5.50%)
21 Oct
1807.10
(-4.49%)
18 Oct
1892.10
(-2.47%)
17 Oct
1939.95
(-2.88%)
16 Oct
1997.45
(3.91%)
15 Oct
1922.20
(8.63%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Bullish
Medium Term Investors

Very Bullish
Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bearish

2117.57

10 DMA
Bullish

2031

20 DMA
Bullish

1926.86

50 DMA
Bullish

1809.22

100 DMA
Bullish

1562.27

200 DMA
Bullish

1424.6


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 12, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 2443.86 2360.93 2133.5 - -
R2 2360.93 2273.83 2112.6 2345.4 -
R1 2215.86 2220.03 2091.7 2184.8 2288.4
P 2132.93 2132.93 2132.93 2117.4 2169.2
S1 1987.86 2045.83 2049.9 1956.8 2060.4
S2 1904.93 1992.03 2029 1889.4 -
S3 1759.86 1904.93 2008.1 - -

Key Metrics

Shareholding Pattern

  66.73% Total Promoter Holding
0% Mutual Fund Holdings
1.16% FIIs
31.95% Non Institution
0% Insurance Companies
0% Custodians
0.16% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Beta Drugs Ltd Quaterly Results


INCOME
PROFIT
EPS

Beta Drugs Ltd Quaterly Results


INCOME
PROFIT
EPS

Profit & Loss (Figures in Rs. Crores)


Beta Drugs Ltd Profit & Loss


Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 51.49 69.97 92.07 118.39 186.35 232.57 315.31
PROFIT 6.76 8.04 9.44 11.72 24.83 30.72 36.44
EPS 7.82 9.3 9.79 12.2 25.82 31.95 37.9

Beta Drugs Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 0.37 26.6 41.22 51.49 61.04 65.54 81.45 124.85 162.08 206.33
PROFIT -0.11 1.13 4.27 6.76 7.71 7.1 6.98 14.25 18.82 21.94
EPS 0 11.23 42.27 7.82 8.92 7.39 7.26 14.82 19.57 22.82

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :
Share Capital 9.619.619.619.619.618.658.65
Reserves Total 147.5113.2782.735947.532.2724.23
Total Shareholders Funds157.11122.8892.3468.6157.1140.9232.88
Secured Loans 14.5320.3320.617.4622.5419.977.5
Unsecured Loans 00000.0300
Total Debt14.5320.3320.617.4622.5719.977.5
Other Liabilities6.275.554.714.463.12.270.43
Total Liabilities177.91148.76117.6590.5382.7863.1640.81
APPLICATION OF FUNDS :
Gross Block 109.4999.3782.1761.1458.2925.3818.06
Less: Accumulated Depreciation44.936.6127.2221.1714.467.714.87
Net Block64.5962.7654.9539.9743.8317.6713.19
Capital Work in Progress0002.810.0814.691.35
Investments 00.780.780.780.350.350
Inventories 49.8130.6222.4816.0412.359.532.8
Sundry Debtors 79.2462.7245.1833.8831.9325.0314.44
Cash and Bank Balance28.6319.1617.3210.425.393.311.91
Loans and Advances 20.1815.1811.977.76.375.093.17
Total Current Assets177.87127.6996.9668.0456.0442.9532.32
Current Liabilities 73.3845.4936.5625.5523.1918.648.3
Provisions 2.84.173.631.421.20.740.33
Total Current Liabilities & Provisions76.1849.6640.1926.9624.419.388.63
Net Current Assets101.6978.0356.7741.0731.6423.5723.7
Deferred Tax Assets1.411.20.680.650.170.290
Deferred Tax Liability000000.150.15
Net Deferred Tax1.411.20.680.650.170.14-0.15
Other Assets10.2364.485.266.726.742.72
Total Assets177.92148.77117.6790.5482.7863.1640.8
Contingent Liabilities1.551.55000.7300
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 9.619.619.619.619.618.658.651.011.011.01
Reserves Total 106.486.6467.8553.846.8331.9524.235.061.190.06
Total Shareholders Funds116.0196.2577.4663.4156.4440.632.886.072.21.07
Secured Loans 5.685.956.845.198.886.097.55.855.371.99
Unsecured Loans 00000.031.7902.362.972.78
Total Debt5.685.956.845.198.917.887.58.218.344.77
Other Liabilities3.182.592.441.820.860.580.430.250.060
Total Liabilities124.87104.7986.7470.4266.2149.0640.8114.5310.65.84
APPLICATION OF FUNDS :
Gross Block 65.1259.8453.8643.1541.5419.4118.0611.129.11.07
Less : Accumulated Depreciation 28.6425.0719.8115.149.877.294.873.021.760.52
Net Block 36.4834.7734.0528.0131.6712.1213.198.17.340.55
Capital Work in Progress0001.90.0814.691.35005.71
Investments 5.776.556.546.546.121.610000
Inventories 21.9413.668.477.76.16.412.82.42.861.28
Sundry Debtors 50.4943.5931.3520.8120.9117.3314.4410.514.40.08
Cash and Bank Balance27.217.7915.588.274.162.9211.910.140.130.06
Loans and Advances 14.059.957.356.7864.733.172.050.410.27
Total Current Assets113.688562.7643.5537.1731.3932.3215.117.81.69
Current Liabilities 43.7426.3122.2215.2315.4215.018.37.744.572.17
Provisions 1.872.941.940.570.560.580.330.860.030
Total Current Liabilities & Provisions45.6129.2524.1615.8115.9815.598.638.64.62.17
Net Current Assets68.0755.7538.627.7421.1915.823.76.53.2-0.48
Deferred Tax Assets0.810.890.60.3700.250000
Deferred Tax Liability00000.030.150.150.0800
Net Deferred Tax0.810.890.60.37-0.030.1-0.15-0.0800
Other Assets13.736.836.945.867.184.742.7200.070.07
Total Assets124.86104.7986.7470.4266.2149.0640.814.5310.615.84
Contingent Liabilities1100000000

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...48.75
Depreciation9.78
Interest (Net)1.74
Total Adjustments (PBT and Ext...-4.25
Operating Profit before Workin...44.51
Trade and 0ther Receivables-16.52
Inventories-19.19
Trade Payables19.03
Loans and Advances-1.06
Total Adjustments (OP before W...-13.58
Cash Generated from/(used in) ...30.93
Cash Flow before Extraordinary...30.93
Net Cash from Operating Activi...30.93
Purchased of Fixed Assets-11.62
Sale of Investments0.78
Interest Received1.08
Net Cash used in Investing Act...-13.97
Of the Long Tem Borrowings-0.56
Of the Short Term Borrowings-4.11
Interest Paid-2.82
Net Cash used in Financing Act...-7.49
Net Profit before Tax and Extr...29.48
Depreciation4.72
Interest (Net)-0.49
Total Adjustments (PBT and Ext...-6.29
Operating Profit before Workin...23.19
Trade and 0ther Receivables-6.9
Inventories-8.27
Trade Payables12.59
Loans and Advances-0.99
Total Adjustments (OP before W...-2.01
Cash Generated from/(used in) ...21.19
Cash Flow before Extraordinary...21.19
Net Cash from Operating Activi...21.19
Purchased of Fixed Assets-6.43
Sale of Investments0.78
Interest Received1.54
Net Cash used in Investing Act...-11.02
Proceed from 0ther Long Term B...0.29
Interest Paid-1.05
Net Cash used in Financing Act...-0.76

Company Details

Registered Office
AddressVillage Nandpur,
CityBaddi
StateHimachal Pradesh
Pin Code174101
Tel. No.91-1795-236196
Fax. No.
Emailinfo@betadrugslimited.com
Internethttp://www.betadrugslimited.com
Registrars
AddressVillage Nandpur
CityBaddi
StateHimachal Pradesh
Pin Code174101
Tel. No.91-1795-236196
Fax. No.
Emailinfo@betadrugslimited.com
Internethttp://www.betadrugslimited.com
Management
Name Designation
Balwant Singh.Whole-time Director
Varun BatraJoint Managing Director
Rahul BatraChairperson & M D
Manmohan KhannaIndependent Director
Rohit PartiIndependent Director
Rajni BrarCompany Sec. & Compli. Officer
Seema ChopraWhole-time Director
Ashutosh ShuklaWhole-time Director